Navigation Links
Van in Medical Technology

Infant Blood May Provide Insights into Diseases Present at Birth

... GRAND RAPIDS, Mich., Dec. 15 /PRNewswire/ -- van Andel Institute (VAI) researchers are the first ... Established by Jay and Betty van Andel in 1996, van Andel Institute is an independent research ...

Agendia Supports High Profile CME Symposium and Presents Compelling Data at the 2008 San Antonio Breast Cancer Symposium

... Decisions: "RNA". Presenter: Laura van 't Veer, PhD, Netherlands Cancer Institute. ... in breast cancer patients." Presenter: Laura van 't Veer, PhD, Netherlands Cancer Institute. ... Netherlands Cancer Institute/Antoni van Leeuwenhoek Hospital, Amsterdam, the Netherlands ...

VAI Finding Could Lead to New Drugs for Anxiety, Depression

... in the Laboratory of Structural Sciences at van Andel Institute (VAI) have determined how the ... going forward." Established by Jay and Betty van Andel in 1996, van Andel Institute is an independent research ...

VAI Findings Could Aid Diagnosis and Treatment of Several Types of Kidney Cancer

... van Andel Institute researchers are first to ... GRAND RAPIDS, Mich., Sept. 12 /PRNewswire/ -- van Andel Institute (VAI) researchers have identified ... disease each year. Established by Jay and Betty van Andel in ...

Ipsogen Announces Three Studies at the American Society of Clinical Oncology (ASCO) Meeting Extending the Utility of the Genomic Grade Index for Predicting Response to Chemotherapy in Breast Cancer

... study (abstract 11048, (4)), presented by Dr. van Laere from Antwerp University, Belgium, validates ... (4) S. J. van Laere, G. G. van den Eynden, ....

Study Finds Repeated Episodes of Stent Thrombosis Common

... College of Cardiology (ACC). Jochem Wouter van Werkum, MD, a cardiologist at St Antonius ... usual risk of a repeat episode (p=0.0127). Dr. van Werkum and his colleagues concluded that ... first stent thrombosis should be avoided. Dr. van Werkum will present the results of the "Dutch ...

QIAGEN and Center for Molecular Medicine Create Research Collaboration for Molecular Diagnostic Markers for Breast Cancer, Other Women's Health Issues

... software and database system developed at the van Andel Research Institute. This specialized ... Webb, Ph.D. and Jeremy Miller, Ph.D., of the van Andel Research Institute, a co-founding joint ... capabilities of CMM joint venture partners the van Andel Institute and Spectrum Health. "CMM is ...

First Patient Enrolled in Europe in Ovature Phase III Ovarian Cancer Trial

... Eur J Gynaecol Oncol. 2005;26(4):386-90. (2) van der Burg ME, van der Gaast A, Vergote I, Burger CW, van Doorn HC, de Wit R, Stoter G, Verweij J. ...

SYNTAX Analysis Finds Treatment With TAXUS(R) Express2(R) Stent System More Cost Effective Than Bypass Surgery in Patients With Complex Coronary Artery Disease

... year were also lower with PCI. Analysis of the data was presented by Ben van Hout, Ph.D., of the University of Utrecht, The Netherlands, at the annual ... first year following treatment, as compared to CABG patients," said Dr. van Hout. "This analysis will be especially helpful to physicians and ...

DaVita Abstracts Accepted Into National Kidney Foundation's 2009 Spring Symposium

... and Iron Status in Hemodialysis Patients Authors: David B. van Wyck(1), Harry Alcorn(1), Resmi Gupta(2) (1)DaVita, Inc., El ... Jessica E Miller(1), Elani Streja(1), Csaba P Kovesdy(2), David van Wyck(3), Allen R. Nissenson(3), and Kamyar Kalantar- Zadeh(1) ...

Karmanos Cancer Institute Research Supports Role of Inflammation to Determine Lung Cancer Risk, Particularly in African-American Women

... by race, according to Karmanos Principal Investigator Alison L. van Dyke, MD/PhD Candidate, Class of 2011. Genetic variation was evaluated by ... to confirm these findings," said Dr. Schwartz. According to van Dyke, this type of information might be used to better predict who to ...

Economy is Driving Many Osteoporotic Women to Retire Later - But Their Ability to Work May Be Undermined by Sub-Optimal Management of Their Disease

... fracture and subsequent fracture risk. Bone 35:375. (13) Clinical subsequent fractures cluster in time after first fractures. T A C M van Geel, et al, Annals of the Rheumatic Diseases 2009;68:99-102. (14) http://orthoinfo.aaos.org/topic.cfm?topic=A00121 , accessed ...

Responses After Completion of Therapy Increase Pixantrone Complete Remission (CR)/Unconfirmed Complete Remission (CRu) Rate to 24% and Overall Response Rate (ORR) to 40% Compared to 7% and 14% for Comparator Agents in Phase III EXTEND Trial in 3rd Line Th

... III EXTEND PIX 301 clinical trial of pixantrone (the "PIX 301 EXTEND trial") is being presented at the Pan Pacific Lymphoma conference by Dr. Richard van der Jagt of the Ottawa General Hospital. Pixantrone PIX 301 EXTEND Trial Follow-up Data and Subgroup Analyses Initial follow-up data in ...

AMT Receives EMEA Orphan Drug Designation for Acute Intermittent Porphyria

... approval. "We are proud to have received this Orphan Drug Designation for the treatment of acute intermittent porphyria," said Sander van Deventer, Chief Executive Officer of AMT. "This designation is an important step in the development of a treatment for this seriously debilitating ...

Glivec(R) is the First Adjuvant Treatment Approved in the UK to Delay Return of Gastrointestinal Cancer After Surgery

... d=aeaa5a245ca1fddb:3c6bded9:1201d7429fe:-15be1237448848073. Last accessed 14.04.09 3. van den Abbeele A., Benjamin R., Blanke C, et al. Clinical Management of GIST. Recurrence patterns and prognostic factors for survival. Highlights From ...

Trius Therapeutics Announces Presentations Featuring Torezolid Antibiotic at the 19th European Congress of Clinical Microbiology and Infectious Diseases

... and shows activity towards intraphagocytic linezolid-sensitive and linezolid-resistant S. aureus ; S. Lemaire, K. Kosowska-Shick, P. Appelbaum, F. van Bambeke, P. Tulkens P 1090 : The safety of single ascending oral doses of TR-701, a novel oxazolidinone prodrug antibiotic; P. Bien, P. ...

Investigational Genetic Test May Help Address Common Problems in Prostate Cancer Diagnosis

... specimens." John Ward, et al. (4) AUA poster #1814, "Feasibility of the PCA3 urine test in a community- based screening setting." Adrie van Bokhoven, et al. (5) UROLOGY(R) (69:532-535, 2007). Contact: Michael Watts Vice president, investor relations and corporate ...

ULURU Inc. to Present Altrazeal(TM) Clinical Evidence and Advanced Therapeutic Research at the Diabetic Foot Global Conference (DFCon) 2009

... quarter ended September 30, 2008, and other reports filed by us with the Securities and Exchange Commission. Contact: Company Renaat van den Hooff President & CEO Terry K. Wallberg Vice President & CFO (214) 905-5145 ...

Nobilon Advances First Vaccine Into Human Trials - Intranasal Influenza Vaccine Begins Phase I Clinical Development

... program of Nobilon," said Gelmer Leibbrandt, general manager of Nobilon. "This is an important milestone in the young history of our company." Han van den Bosch, Director R&D, stated: "We are encouraged by the positive results obtained in the pre-clinical development of our candidate vaccine so ...

Can Exercising Your Brain Prevent Memory Loss?

... these findings with additional research." The study was supported by the National Institutes of Health, Robert H. and Clarice Smith and Abigail van Buren Alzheimer's Disease Research Program and the Robert Wood Johnson Foundation. Additional audio and video resources, including excerpts from ...

Agendia's MammaPrint(R) Predicts Response to Neoadjuvant Chemotherapy in Breast Cancer

... cancer diagnostics, today announced MammaPrint(R)'s ability to predict response to neoadjuvant chemotherapy in breast cancer. Dr. Laura van 't Veer, from the Netherlands Cancer Institute, presented the data at the 2008 San Antonio Breast Cancer Symposium (SABCS) during the session ...

Long-Term Study Evaluates Boosted PREZISTA(R) Vs. Lopinavir/Ritonavir as Part of HIV Combination Therapy in Treatment-Naive Adults

... not undertake to update any forward-looking statements as a result of new information or future events or developments.) Contacts: Pam van Houten Mobile: (908) 295-7367 ...

ULURU Inc. Announces the Commencement of First Clinical Study Using Altrazeal(TM) Silver

... data to apply for a CE mark which will enable Altrazeal(TM) Silver to be marketed in Europe and Canada. Commenting on the clinical study, Renaat van Den Hooff, Executive Vice President of Operations stated, "Silver containing dressings are used extensively in the skin graft donor site indication ...

Ninety-Six Week Data on Tibotec Investigational NNRTI, TMC278, Presented at AIDS 2008

... of innovative HIV/AIDS drugs and anti-infectives for diseases of high unmet medical need. Media Contacts: Karen Manson - 32-479-89-47-99 Pam van Houten - 908-295-7367 Investor Relations Contacts: Lesley Fishman - 732-542-3922 Louise Mehrota - 732-524-6491 ...

Two New Alzheimer's Disease Studies Show Advances Against Different Treatment Targets

... Mayo Clinic study of aging: Incidence of mild cognitive impairment." (Funders: National Institute on Aging; Robert H. and Clarice Smith and Abigail van Buren Alzheimer's Disease Research Program of the Mayo Clinic) -- Donald E. Schmechel. "A phase 2, double-blind, placebo-controlled study to ...

Wyeth Applauds Six Countries Across Europe, and the Middle East, That Recently Announced the Inclusion of the 7-Valent Pneumococcal Conjugate Vaccine (PCV7) in Their Immunization Schedules

... Germany, France and the UK highlight the impact of the vaccine in countries where it is part of the national immunization schedule," says Dr Mark van der Linden, Head of the National Reference Center for Streptococci at the Institute of Medical Microbiology, RWTH-Aachen, Germany. The World Health ...

Atrium Medical Corporation Announces First Implant of First-in-Man CINATRA(TM) Voclosporin Coated Coronary Stent

... use study of voclosporin on an implantable medical device will enroll 100 patients, and will be conducted at seven hospitals in Belgium with Glenn van Langenhove, MD, PhD of Middelheim Hospital, Antwerp, as the study's Principal Investigator. The primary endpoint of the trial is to evaluate the ...

Nektar Announces Expanded Phase 2 Clinical Development Plan For NKTR-102 (PEG-irinotecan)

... and Glossary 1 Simon, Richard, "Optimal Two-Stage Designs for Phase II Clinical Trials," Controlled Clinical Trials 10:1-10 (1989) 2 E. van Cutsem, I. Lang, G. D'haens, V. Moiseyenko, J. Zaluski, G. Folprecht, S. Tejpar, O. Kisker, C. Stroh, P. Rougier, "KRAS status and efficacy in ...

Patients with Pancreatic Cancer Can Benefit From Avastin(R) Plus Tarceva(R)

... are diagnosed with advanced disease. "For patients with advanced pancreatic cancer, the treatment options are limited," commented Professor Eric van Cutsem, Professor of Medicine, Gastrointestinal Oncology Unit, University Hospital Gasthuisberg, Leuven, Belgium. "The interesting results show the ...

AstraZeneca Submits sNDA for NEXIUM(R) I.V. for Peptic Ulcer Bleed Indication

... mortality from peptic ulcer bleeding and perforation: a Danish population-based cohort study. Diabetes Care 2006;29(4):805-10. (8) van Leerdam ME et al Acute upper GI bleeding: Did anything change? Time trend analysis of incidence and outcome of acute upper GI bleeding ...

St. Jude Study Shows How T Cell's Machinery Dials Down Autoimmunity

... and Richard Smeyne (St. Jude); Harvir Singh, Andrzej Chruscinski and Paul Utz (Stanford University School of Medicine, Stanford, Calif.); and Nicolai van Oers (The University of Texas Southwestern Medical Center, Dallas). This work was supported by the National Institutes of Health, a Cancer Center ...

ACR Supports American Cancer Society Inclusion of CT Colonography (Virtual Colonoscopy) as Recommended Screening Tool for Colorectal Cancer in New Screening Guidelines

... the disease for more patients, increasing the chance of successful treatment, and potentially reduce colorectal cancer deaths nationwide," said Arl van Moore Jr., M.D., FACR, chair of the ACR Board of Chancellors. Results of the National CT Colonography Trial coordinated by the American College ...

Test for Life Campaign Screens Record Number of DC Residents for HIV/AIDS

... Test for Life: Maura O'Connor (202) 572-6252 Washington Wizards Communications Department: Zack Bolno, Brian Sereno, Daren Jenkins or Whitney van Wyk at 202-661-5112 Verizon Washington, DC: Christy Reap 202-392-1021 ...

Mayo Clinic Finds Capsule Endoscopy Can Detect Intestinal Damage Caused by Celiac Disease

... damage both prior to and following treatment." Other members of the Mayo Clinic research team included Alberto Rubio Tapia, M.D., Carol van Dyke, Deanna Brogan, Mary Knipschield, Brian Lahr, Ashwin Rumalla, Alan Zinsmeister, Ph.D., and Christopher Gostout, M.D. Each year, physicians ...

Bionomics Achieves US$1 Million Milestone Payment from Genmab

... to reach the next level of development with these targets and look forward to continuing the collaboration with Bionomics." Professor Jan G J van de Winkel, PhD, Chief Scientific Officer of Genmab added: "This milestone has been reached following extensive studies by Genmab on the Bionomics ...

New 48-Week Efficacy and Safety Data Presented for INTELENCE(TM) (etravirine) as Part of HIV Combination Therapy

... undertake to update any forward-looking statements as a result of new information or future events or developments. Media Contact: Pamela van Houten 908-541-4137 (office) 908-295-7367 (mobile) Investor Relations: Lesley Fishman ...

Supplemental New Drug Application for PREZISTA(TM) Submitted to U.S. Food and Drug Administration

... therapeutics that help healthcare professionals address serious unmet needs in people living with HIV. Media Contact: Pamela van Houten Office: 908-541-4137 Mobile: 908-295-7367 Investor Contact: Louise Mehrotra (732) 524-6491 ...

WaveSense Blood Glucose Meter One of Few Brands to Pass Rigorous TNO Tests

... Glucose also carries the CE Marking. "Receiving the TNO approval is a testament to the quality and accuracy of WaveSense products," said Dr. E. van Ballegooie, one of the leading physicians in the Belgium/Netherlands/Luxembourg region. "Roche and Abbott are the other major brands to receive the ...

ACRIN Study Endorses Virtual Colonoscopy - Validation for Colon CAD Software Maker Medicsight plc

... readers, CT colonography is a viable and robust screening tool for colorectal cancer." For further information: MGT Capital Investments Alex van Klaveren Tel: +1 646 257 2674 http://www.mgtci.com Media enquiries: KCSA Worldwide Todd Fromer / Garth Russell 212-896-1215 / ...

New Phase 3 Study in Treatment-Naive Adults with HIV Evaluates Efficacy and Safety of Once-Daily PREZISTA(TM)/ritonavir vs. KALETRA(R) as Part of HIV Combination Therapy

... a trademark owned by Gilead Sciences, Inc. 2. Kaletra(R) (lopinavir/ritonavir) is a trademark owned by Abbott Laboratories Contacts: Pam van Houten Office: (908) 541-4137 ...
Other Contents
(Date:8/19/2014)... MA -- MIT chemical engineers have devised a new ... are released slowly over a few weeks. When applied ... the body to rapidly form new bone that looks ... type of coated scaffold could offer a dramatic improvement ... involves transplanting bone from another part of the patient,s ...
(Date:8/19/2014)... born with neonatal abstinence syndrome (NAS) secondary to ... going through withdrawal than others, but the underlying ... epigenetic (when genes are turned on or off) ... researchers at Boston University School of Medicine (BUSM) ... of its kind study to identify some of ...
(Date:8/19/2014)... seas during warm phases and became extinct during cold ... a link between marine crocodilian diversity and the evolution ... 140 million years. , The research, led by ... and formerly from the University of Bristol, UK is ... crocodiles are ,cold-blooded, animals that mainly live in fresh ...
Breaking Biology News(10 mins):Engineering new bone growth 2Engineering new bone growth 3In-utero methadone, Subutex exposure could alter gene expression, cause severe Neonatal Abstience Syndrome 2Evolution of marine crocodilians constrained by ocean temperatures 2
(Date:8/20/2014)... Dennis Thompson HealthDay Reporter ... birth rates fell dramatically during the past two decades, plummeting ... government report shows. An estimated 4 million fewer births ... to researchers from the U.S. Centers for Disease Control and ... me from the report," said Bill Albert, chief program officer ...
(Date:8/20/2014)... Bottom Line: Less than 42 percent of women ... and the factors associated with foregoing reconstruction included ... being older. , Author: Monica Morrow, M.D., of ... and colleagues. , Background: The Women,s Health and ... for breast reconstruction following a mastectomy. Still, most ...
(Date:8/20/2014)... vaccines is now, Free content, The time to ... commentary being published early online today in ... Yale School of Public Health write that the relentless ... outbreak represent a public health crisis that shows no ... have been developed in the last decade, yet the ...
(Date:8/20/2014)... Barbara Bronson Gray HealthDay ... Although it,s extremely rare, colds, flu and other minor ... risk for stroke in children, a new study suggests. ... stroke in the United States, said Dr. Heather Fullerton, lead ... pediatrics at the University of California, San Francisco Benioff Children,s ...
(Date:8/20/2014)... Reinberg HealthDay Reporter WEDNESDAY, ... cancer cells grow may help doctors diagnose and treat the ... investigators have found that the deadliest skin cancers occur most ... a long history of sun exposure. These lesions also ... Rapid cell growth -- called "high mitotic rate" -- ...
Breaking Medicine News(10 mins):Health News:Teen Birth Rate Has Dropped Dramatically in Last Two Decades: CDC 2Health News:Teen Birth Rate Has Dropped Dramatically in Last Two Decades: CDC 3Health News:Patient perspectives on breast reconstruction following mastectomy 2Health News:News from Annals of Internal Medicine 2Health News:Study Ties Colds, Flu to Rare Risk of Stroke in Kids 2Health News:Study Ties Colds, Flu to Rare Risk of Stroke in Kids 3Health News:High-Risk Melanomas Often on Head or Neck, Study Finds 2Health News:High-Risk Melanomas Often on Head or Neck, Study Finds 3
Other TagsOther Tags